Table 1.

Anticoagulant prophylaxis with Enoxaparin for patients with moderate, severe and critical form of COVID-19, which require hospitalization.

	Profile dose	Prophylactic intensified dose	Treatment dose
Target anti-Xa	0.2–0,4 U/mL	0.4–0.8 U/mL	0.6–1.1 U/mL
≤ 2 months	0.75 mg/kg, every 12 h	1.0 mg/kg, every 12 h	1.5 mg/kg, every 12 h
From 2 months till ≤ 18 years:
< 40 kg	0.5 mg/kg, every 12 h	0.75 mg/kg, every 12 h	1.0 mg/kg, every 12 h
> 40 kg	40 mg, 1 time a day	60 mg, every 12 h	40 mg, every 12 h